companydata.dkcompanydata.dk

Selma Diagnostics ApS: Financial statements 2023

CVR: 36961376

Source: annual report 2023, Danish Business Authority

01/01/202331/12/2023

Selma Diagnostics ApS (CVR 36961376) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -1,428,041 and a net result of DKK -1,926,683 compared with DKK -2,768,328 the year before. Equity in the 2023 report amounted to DKK -5,915,615. The company had 2 employees in the financial year.

Gross Profit
DKK -1,428,041
Profit/Loss
DKK -1,926,683
Equity
DKK -5,915,615
Total Assets
DKK 1,098,618
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--1.4 mio.-1.9 mio.-5.9 mio.2
2022--1.6 mio.-2.8 mio.-4 mio.2
2021--1.8 mio.-2 mio.-1.2 mio.2
2020--1.6 mio.-2.4 mio.733 t.3
2019--1.9 mio.-2.7 mio.415 t.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Selma Diagnostics ApS: The 2022 annual report is outJul 3, 2023

Selma Diagnostics ApS has published its annual report for 2022. Gross profit came to DKK -1,636,197, and the net result was DKK -2,768,328.

Selma Diagnostics ApS appoints new auditorFeb 22, 2023

As of February 22, 2023, BDO Holding VII, statsautoriseret revisionsaktieselskab has been appointed auditor of Selma Diagnostics ApS.

Auditor steps down at Selma Diagnostics ApSFeb 22, 2023

As of February 22, 2023, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Selma Diagnostics ApS.

About Selma Diagnostics ApS

Selma Diagnostics ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Andreas Hjarne Kunding. The board consists of Carsten Krogh Gomard (chair), Andreas Hjarne Kunding and John Alexander. The company's owners include John Alexander, CARSTEN GOMARD HOLDING ApS and Selma Diagnostics ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK -1,093,508 and a net result of DKK -3,060,808 compared with DKK -2,178,400 the year before. Equity in the 2025 report amounted to DKK -11,154,823.

Source: annual report 2025, Danish Business Authority